Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jun 17, 2022

50715_rns_2022-06-17_e3c65f0e-ef52-44b7-9bdf-694198399efd.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

17 June 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Description Nature of dealings Purchase Total Total amount Highest (H) Lowest (L)
of relevant / Sale number of paid / received prices paid prices paid
securities shares / received / received
involved
China International 16 June Other types Closing / flattening / unwinding of Sale 10,000 $263,000.0000 $26.3000 $26.3000
Capital Corporation 2022 of securities proprietary positions arising from
Limited (e.g. equity unsolicited client-driven
swaps) dealings. I confirm this was
done no later than the close of
the morning trading session on
the trading day following the
orginating client-driven dealing

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Other tyof secur(e.g. eqswaps) pesitiesuity Closing / flattening / unwinding ofproprietary positions arising fromunsolicited client-drivendealings. I confirm this wasdone no later than the close ofthe morning trading session onthe trading day following the Purchase 10,000 $263,000.0000 $26.3000 $26.3000
orginating client-driven dealing

End

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.